Determining the right path for IRB review is not always straightforward. Before a study can move forward, research teams must understand whether an activity is research, whether it involves human subjects, and which level of review applies. Those determinations help protect participants, support compliance, and set expectations for timelines, documentation, and IRB involvement.
Join WCG IRB experts for the first session in IRB 101, a practical educational series designed to help research teams build confidence in the fundamentals of IRB review. This session will break down the key decision points that determine whether an activity requires IRB oversight and explain how exempt, expedited, and full board review differ in purpose, process, and expectations.
Learning Objectives
After attending this webinar, participants will be able to:
- Identify the threshold questions used to determine whether an activity is research involving human subjects.
- Explain how IRBs assess whether a study may qualify as exempt or be appropriate for expedited review.
- Describe when full board review is required and what research teams should expect from that process.
- Apply a practical decision-making framework to help align submissions with the appropriate level of IRB review.
Please fill out the following form to register for this webinar:
Speakers:
Jyh-Kae Nien
IRB Medical Chair, WCG
Andrea C. Itskovich, MD, CIP
IRB Medical Chair, WCG